Published in Lancet on March 18, 1978
Critical review of clinical trials in senile dementia--II. Postgrad Med J (1987) 0.80
Feeling cold: an unusual brain injury symptom and its treatment with vasopressin. J Neurol Neurosurg Psychiatry (1997) 0.75
Electroencephalographic and early communicative abnormalities in Brattleboro rats. Physiol Rep (2013) 0.75
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med (1992) 5.97
An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut (1965) 5.25
Factors associated with falls in the elderly: a community study. Age Ageing (1981) 3.82
Human parvovirus arthropathy. Lancet (1985) 3.76
Self-poisoning: management of patients in Nottingham, 1976. Br Med J (1978) 3.24
Fractured proximal femur in Newcastle upon Tyne. Age Ageing (1979) 3.13
Qualitative study of interpretation of reassurance among patients attending rheumatology clinics: "just a touch of arthritis, doctor?". BMJ (2000) 3.05
The rationing debate. Rationing health care by age. BMJ (1997) 3.00
The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum (1998) 2.92
Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol (2001) 2.68
Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis (1992) 2.63
Deliberate self-poisoning in the Oxford area. Br J Prev Soc Med (1967) 2.63
Simulating sensory-motor incongruence in healthy volunteers: implications for a cortical model of pain. Rheumatology (Oxford) (2005) 2.52
A prospective study of fractured proximal femur: incidence and outcome. Public Health (1979) 2.51
Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett (1998) 2.49
Renal impairment associated with non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1987) 2.48
The importance of iron in rheumatoid disease. Lancet (1981) 2.44
The patient is not a blank sheet: lay beliefs and their relevance to patient education. Br J Rheumatol (1989) 2.42
Nitrazepam and the elderly. Br Med J (1972) 2.38
Teaching medical gerontology in Europe. Group of European Professors in Medical Gerontology (GEPMG) Age Ageing (1994) 2.32
Continuing worldwide increase in tropospheric methane, 1978 to 1987. Science (1988) 2.30
A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum (1991) 2.18
Hypertension. Br Med Bull (1971) 2.12
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut (1994) 2.10
Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum (1996) 2.07
Description of the analysis of a wide range of volatile organic compounds in whole air samples collected during PEM-tropics A and B. Anal Chem (2001) 2.07
Experience with the random-zero sphygmomanometer. Br J Prev Soc Med (1970) 2.05
A prospective study of fractured proximal femur: factors predisposing to survival. Age Ageing (1979) 2.03
Long-term care in later life. BMJ (1995) 2.02
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem (2000) 1.93
Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology (1992) 1.92
Joint stiffness in a phantom limb: evidence of central nervous system involvement in rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.90
Organic aerosol formation downwind from the Deepwater Horizon oil spill. Science (2011) 1.89
Institutional care and elderly people. BMJ (1993) 1.83
Indices of obesity derived from height and weight in two Polynesian populations. Br J Prev Soc Med (1969) 1.80
Integration of geriatric with general medical services in Newcastle. Lancet (1983) 1.78
Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis. Ann Rheum Dis (1992) 1.77
Fallers, non-fallers and Poisson. Age Ageing (1990) 1.75
Information loss in limb-lead electrocardiograms compared with twelve-lead tracings in a population survey among the elderly. Age Ageing (1976) 1.73
Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in-vivo demonstration of iron-promoted oxidant stress. Lancet (1987) 1.69
A neurogenic mechanism for symmetrical arthritis. Lancet (1989) 1.69
Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull (1995) 1.65
A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant (2006) 1.61
Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis (1991) 1.61
Sodium intake and blood pressure in two Polynesian populations. N Engl J Med (1968) 1.54
Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis (1983) 1.52
Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol (1998) 1.51
Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest (1985) 1.51
Ventilatory control in patients with sleep apnoea and left ventricular dysfunction: comparison of obstructive and central sleep apnoea. Eur Respir J (1998) 1.51
Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) (1977) 1.49
Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience (1990) 1.49
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1981) 1.48
Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis (1986) 1.45
Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis (1993) 1.45
Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun (1998) 1.42
Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis (1985) 1.41
Photosynthetic control of atmospheric carbonyl sulfide during the growing season. Science (2008) 1.40
Geriatric primary care: a European perspective, Part I. Geriatrics (1992) 1.40
Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status. Ann Rheum Dis (1989) 1.40
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut (1996) 1.39
Measuring outcome in rheumatoid arthritis--which measures are suitable for routine clinical use? Br J Rheumatol (1996) 1.39
Cortical origins of pathological pain. Lancet (2000) 1.39
A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). Rheumatology (Oxford) (2003) 1.38
The Tokelau Island migrant study. Int J Epidemiol (1974) 1.36
Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut (1992) 1.36
Oxidants, inflammation, and anti-inflammatory drugs. FASEB J (1988) 1.32
Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J (1991) 1.32
Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull (1993) 1.30
Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Proc Natl Acad Sci U S A (2007) 1.28
Mood states of oncology outpatients: does pain make a difference? J Pain Symptom Manage (1995) 1.25
Neurogenic influences in arthritis. Ann Rheum Dis (1990) 1.23
Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) (1986) 1.22
Cerebral and ocular toxicity induced by desferrioxamine. Q J Med (1985) 1.21
Xanthine oxidoreductase is present in human synovium. Ann Rheum Dis (1987) 1.21
Relation of serum uric acid to body bulk, haemoglobin, and alcohol intake in two South Pacific Polynesian populations. Ann Rheum Dis (1968) 1.20
The effect of synovial iron on the progression of rheumatoid disease. A histologic assessment of patients with early rheumatoid synovitis. Arthritis Rheum (1984) 1.20
Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun (1992) 1.19
Hypoxia and inflammatory synovitis: observations and speculation. Ann Rheum Dis (1991) 1.19
Perimenopausal risk of falling and incidence of distal forearm fracture. BMJ (1989) 1.17
Human xanthine oxidase converts nitrite ions into nitric oxide (NO). Biochem Soc Trans (1997) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Assessment of iron stores in inflammation by assay of serum ferritin concentrations. Br Med J (Clin Res Ed) (1981) 1.16
Fractures of the distal forearm in Newcastle: an epidemiological survey. Age Ageing (1985) 1.15
Synovial fluid ferritin in rheumatoid arthritis. Br Med J (1980) 1.14
Self-poisoning: psychiatric assessment by junior staff. Br Med J (1979) 1.13
Age-specific incidence of Guillain-Barré syndrome in Oxfordshire. Q J Med (1990) 1.12
Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.12
Reactive oxygen species and iron--a dangerous partnership in inflammation. Int J Biochem Cell Biol (1995) 1.12
Adverse reactions to D-penicillamine after gold toxicity. Br Med J (1980) 1.11
Comparison of a cancer-specific locus of control and the multidimensional health locus of control scales in chemotherapy patients. Oncol Nurs Forum (1985) 1.11
The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper. Biochem J (1985) 1.11
The ACE gene and Alzheimer's disease susceptibility. J Med Genet (2000) 1.11
Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett (1992) 1.10
Behavior of patients with lung cancer: description and associations with oncologic and pain variables. Pain (1992) 1.10
Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis (2003) 1.09
Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci U S A (2005) 1.08